Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
By E. Hylek, C. Evans-Molina, Carol Shea, Lori Henault, S. Regan. Circulation, 2007
1,085 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Neurology
View Paper: https://www.semanticscholar.org/paper/b40067d94da32173d00e378e2a3e3144b442d84f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Neurology
Citations in the corpus
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. (2011, background): “2 per 100 patient-years overall).(28) Similarly, in this US-based study, managing warfarin anticoagulation was more challenging in those with congestive heart failure.”
- Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. (2010, neutral): “79) 34 (30-39) Warfarin clopidogrel NA 64 (27-154) 0.”
- The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study (2009, neutral): “10,11 Exclusion criteria were (1) replacement devices, (2) long-standing persistent AF, (3) known reentrant supraventricular tachycardias, (4) terminal illness limiting survival, (5) unable or unwilling to consent, and (6) concurrently enrolled in a conflicting drug or device study.”
- Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014, background): “The evidence to guide dual or triple therapy in patients with AF and clinically apparent CAD is sparse.444 No trials by guest on May 7, 2014http://stroke.ahajournals.org/Downloaded from 30 Stroke July 2014 have been designed to specifically test dual or triple therapy in patients with comorbid AF an”